Worth Venture Partners, LLC Catalyst Biosciences, Inc. Transaction History

Worth Venture Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.93 - $7.15 $489,534 - $709,973	-99,297 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$4.55 - $7.29 $130,521 - $209,120	-28,686 Reduced 22.41%	99,297 $627,000
Q2 2020 Aug 14, 2020	SELL	$3.76 - $8.01 $4,448 - $9,475	-1,183 Reduced 0.92%	127,983 $751,000
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $452,081 - $1.1 Million	129,166 New	129,166 $564,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.